USPTO serial 79429030
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals and veterinary preparations, in particular for the prevention and treatment of cartilage and bone diseases; chemicals for medical purposes, in particular for the prevention and treatment of cartilage and bone diseases; biological preparations for use in cell cultures for medical purposes; medicines for use in human and veterinary medicine for the treatment of bone diseases, osteoarthritis, cartilage defects, arthrosis and traumatic cartilage injuries; drug delivery agents in the form of tablets, capsules, pastilles, and granules that facilitate the delivery of pharmaceutical preparations; ointments for pharmaceutical purposes for the treatment of bone diseases, osteoarthritis, cartilage defects, arthrosis and traumatic cartilage injuries; injection solutions for pharmaceutical purposes for the treatment of bone diseases, osteoarthritis, cartilage defects, arthrosis and traumatic cartilage injuries; dietetic foods and beverages adapted for use in human and veterinary medicine; therapeutic food for dietetic medical purposes; medicinal drinks; dietary supplements, in particular for medical purposes; vitamin and multi-vitamin preparations, in particular for medical purposes; mineral supplements and mineral preparations, in particular for medical purposes; biological and chemical preparations for medical diagnostic purposes for use in laboratories, pharmacies and doctors' surgeries; chemical test preparations for medical diagnostic purposes, in particular reagents, standard solutions, biological indicators and cell culture media; pre-filled syringes sold filled with cell growth factors, analgesics, hyaluronic acid and its derivates, vitamins and minerals | ACTIVE | — |
| 010 | Surgical apparatus and instruments; medical and dental apparatus and instruments, namely, arthroscopic trocar, arthroscopic working sleeves, arthroscopic drills and arthroscopic plungers; vials sold empty for the purpose of medical infusions; medical analytical apparatus, namely, X-ray apparatus, computed tomography apparatus, magnetic resonance imaging apparatus and arthroscopes; implants consisting of artificial materials for use in human and veterinary medicine, in particular for the prevention and treatment of cartilage and bone diseases | ACTIVE | — |
| 016 | Printed matter, namely brochures for patients and magazines with advertising, including for pharmacies and doctors, all the aforesaid relating to the prevention and treatment of cartilage and bone diseases | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 25, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 25, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 7, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 7, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 1, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 11, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 11, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 11, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 11, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 11, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 10, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 10, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 10, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 25, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 10, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 10, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 1, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 31, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 5, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 1, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 1, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 31, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |